NEWS
-
MEDIA
Upcoming Feature on NHK World JAPAN Science View: Freeing Patients from Dialysis! -Dr. Kenji OSAFUNE’s Challenge
-
PR
Rege Nephro’s Chief Executive Officer gave a lecture at Regenerative Medicine Expo[Tokyo].
-
PR
Rege Nephro CO., Ltd. Announces Patient Enrollment for Phase II Clinical Trial of Tamibarotene for ADPKD
-
PR
Phase II clinical trial begins for polycystic kidney disease drug candidate identified by iPS cell-based drug discovery
-
PR
Rege Nephro exhibited at “JAPAN KYOTO TRADE EXIBITION 2024” held in Dubai, UAE
-
Rege Nephro’s Chief Executive Officer gave a lecture at Regenerative Medicine Expo[Tokyo].
-
Rege Nephro CO., Ltd. Announces Patient Enrollment for Phase II Clinical Trial of Tamibarotene for ADPKD
-
Phase II clinical trial begins for polycystic kidney disease drug candidate identified by iPS cell-based drug discovery
-
Rege Nephro exhibited at “JAPAN KYOTO TRADE EXIBITION 2024” held in Dubai, UAE
-
Rege Nephro exhibited at “InnoVision from Kyoto University: Seeing the Future through Innovation” held in Singapore
-
Upcoming Feature on NHK World JAPAN Science View: Freeing Patients from Dialysis! -Dr. Kenji OSAFUNE’s Challenge
-
Our business was introduced in Science Japan, an online magazine published by JST.
-
An article about Toshihiro Ishikiriyama, our president, was published in AnswersNews, serial column: Venture Round Visit Report.
-
Featured in Nikkei newspaper, its electronic version, Asahi Shimbun DIGITAL and many other media.
-
Published in the Nikkei newspaper and the electronic version.